Australia markets close in 1 hour 24 minutes

Kaleido Biosciences, Inc. (KLDO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 03:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.26k
Enterprise value -16.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)0.00
Enterprise value/revenue -15.20
Enterprise value/EBITDA 0.20

Trading information

Stock price history

Beta (5Y monthly) 36.97
52-week change 3-50.00%
S&P500 52-week change 321.33%
52-week high 30.2500
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 32.95k
Avg vol (10-day) 31.72k
Shares outstanding 542.62M
Implied shares outstanding 642.62M
Float 842.45M
% held by insiders 10.00%
% held by institutions 10.03%
Shares short (31 Mar 2022) 42.34M
Short ratio (31 Mar 2022) 429.34
Short % of float (31 Mar 2022) 414.19%
Short % of shares outstanding (31 Mar 2022) 45.49%
Shares short (prior month 28 Feb 2022) 42.16M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,974.39%

Management effectiveness

Return on assets (ttm)-99.93%
Return on equity (ttm)-580.57%

Income statement

Revenue (ttm)1.1M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)102.50%
Gross profit (ttm)N/A
EBITDA -85.16M
Net income avi to common (ttm)-90.29M
Diluted EPS (ttm)-2.1600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)38.47M
Total cash per share (mrq)0.9
Total debt (mrq)21.69M
Total debt/equity (mrq)204.52%
Current ratio (mrq)1.42
Book value per share (mrq)0.25

Cash flow statement

Operating cash flow (ttm)-77.09M
Levered free cash flow (ttm)-46.02M